Difference between revisions of "Thomas C. Quinn"
Jump to navigation
Jump to search
WikiModEn2 (talk | contribs) (Add publcations.) |
m (adjusted content) |
||
| Line 1: | Line 1: | ||
| − | '''Thomas C. Quinn''', | + | '''Thomas C. Quinn''', {{MD}}, {{MS}}, is the Chief of the International [[HIV]]/STD Section of the [https://www.niaid.nih.gov/ National Institute of Allergies and Infectious Diseases] under [[Anthony Fauci]]. He previously was at [[Johns Hopkins University]]. |
Quinn is an associate of circumcision promoters [[Aaron Tobian]], [[Maria Wawer]], and [[Ronald H. Gray]]. His duties include "development and evaluation of novel interventions to prevent HIV transmission, including microbicides, circumcision and vaccines."<ref>{{REFweb | Quinn is an associate of circumcision promoters [[Aaron Tobian]], [[Maria Wawer]], and [[Ronald H. Gray]]. His duties include "development and evaluation of novel interventions to prevent HIV transmission, including microbicides, circumcision and vaccines."<ref>{{REFweb | ||
|url=https://www.niaid.nih.gov/research/thomas-quinn-md | |url=https://www.niaid.nih.gov/research/thomas-quinn-md | ||
| − | |||
|title=Thomas C. Quinn, M.D., M.Sc. | |title=Thomas C. Quinn, M.D., M.Sc. | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|publisher=NIAID | |publisher=NIAID | ||
| − | |||
|date=2018-01-10 | |date=2018-01-10 | ||
|accessdate=2022-01-01 | |accessdate=2022-01-01 | ||
| − | |||
| − | |||
}}</ref> | }}</ref> | ||
| + | |||
{{PUB}} | {{PUB}} | ||
* {{REFjournal | * {{REFjournal | ||
|last=Quinn | |last=Quinn | ||
|first=Thomas C. | |first=Thomas C. | ||
| − | |init= | + | |init=TC |
| − | |author-link= | + | |author-link=Thomas C. Quinn |
|etal=no | |etal=no | ||
|title=Circumcision and HIV transmission | |title=Circumcision and HIV transmission | ||
| − | |||
| − | |||
|journal=Curr Opin Infect Dis | |journal=Curr Opin Infect Dis | ||
| − | |||
|date=2007-02 | |date=2007-02 | ||
|volume=20 | |volume=20 | ||
|issue=1 | |issue=1 | ||
| − | | | + | |pages=33-8 |
| − | |||
| − | |||
|url=https://journals.lww.com/co-infectiousdiseases/Abstract/2007/02000/Circumcision_and_HIV_transmission.7.aspx | |url=https://journals.lww.com/co-infectiousdiseases/Abstract/2007/02000/Circumcision_and_HIV_transmission.7.aspx | ||
| − | |||
| − | |||
|pubmedID=17197879 | |pubmedID=17197879 | ||
| − | |||
|DOI= 10.1097/QCO.0b013e328012c5bc | |DOI= 10.1097/QCO.0b013e328012c5bc | ||
|accessdate=2022-01-01 | |accessdate=2022-01-01 | ||
}} | }} | ||
| − | *{{REFjournal | + | * {{REFjournal |
|last=Gray | |last=Gray | ||
| − | |first= | + | |first=Ronald H. |
|init=RH | |init=RH | ||
| − | |author-link= | + | |author-link=Ronald H. Gray |
|last2=Kiwanuka | |last2=Kiwanuka | ||
|first2= | |first2= | ||
| Line 55: | Line 39: | ||
|first3= | |first3= | ||
|init3=TC | |init3=TC | ||
| − | |author3-link= | + | |author3-link=Thomas C. Quinn |
|etal=yes | |etal=yes | ||
|title=Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team | |title=Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team | ||
| − | + | |journal=AIDS | |
| − | |||
| − | |journal= AIDS | ||
| − | |||
|date=2000-10-20 | |date=2000-10-20 | ||
|volume=14 | |volume=14 | ||
|issue=15 | |issue=15 | ||
| − | + | |pages=2371-81 | |
| − | |||
| − | |pages=2371-81 | ||
|url=https://journals.lww.com/aidsonline/Fulltext/2000/10200/Male_circumcision_and_HIV_acquisition_and.19.aspx | |url=https://journals.lww.com/aidsonline/Fulltext/2000/10200/Male_circumcision_and_HIV_acquisition_and.19.aspx | ||
| − | |||
|quote=The assessment of circumcision for HIV prevention is complex and requires randomized trials. | |quote=The assessment of circumcision for HIV prevention is complex and requires randomized trials. | ||
|pubmedID=11089626 | |pubmedID=11089626 | ||
| − | + | |DOI=10.1097/00002030-200010200-00019 | |
| − | |DOI=10.1097/00002030-200010200-00019 | ||
|accessdate=2022-01-01 | |accessdate=2022-01-01 | ||
}} | }} | ||
| + | |||
| + | {{ABBR}} | ||
{{REF}} | {{REF}} | ||
| + | {{DEFAULTSORT:Quinn, Thomas C.}} | ||
| − | [[Category: | + | [[Category:Person]] |
[[Category:Male]] | [[Category:Male]] | ||
| + | |||
[[Category:Physician]] | [[Category:Physician]] | ||
[[Category:Researcher]] | [[Category:Researcher]] | ||
[[Category:Promoter]] | [[Category:Promoter]] | ||
| + | |||
| + | [[Category:USA]] | ||
Revision as of 14:51, 1 January 2022
Thomas C. Quinn, M.D.[a 1], M.S.[a 2], is the Chief of the International HIV/STD Section of the National Institute of Allergies and Infectious Diseases under Anthony Fauci. He previously was at Johns Hopkins University.
Quinn is an associate of circumcision promoters Aaron Tobian, Maria Wawer, and Ronald H. Gray. His duties include "development and evaluation of novel interventions to prevent HIV transmission, including microbicides, circumcision and vaccines."[1]
Publications
Quinn TC. Circumcision and HIV transmission. Curr Opin Infect Dis. February 2007; 20(1): 33-8. PMID. DOI. Retrieved 1 January 2022.- Gray RH, Kiwanuka N, Quinn TC, et al. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS. 20 October 2000; 14(15): 2371-81. PMID. DOI. Retrieved 1 January 2022.
Quote:The assessment of circumcision for HIV prevention is complex and requires randomized trials.
Abbreviations
- ↑
Doctor of Medicine
, Wikipedia. Retrieved 14 June 2021. In the United Kingdom, Ireland and some Commonwealth countries, the abbreviation MD is common. - ↑
Master of Science
, Wikipedia. Retrieved 13 October 2021. (Latin: magisterii scientiae; also abbreviated MS, MSc, M.Sc., SM, S.M., ScM or Sc.M.)
References
- ↑ (10 January 2018).
Thomas C. Quinn, M.D., M.Sc.
, NIAID. Retrieved 1 January 2022.